GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing a ...
Pharmabiz1d
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
Hosted on MSN2d
GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
The five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
Healthline25d
Understanding Optic Neuritis
when part of your optic nerve is not getting enough blood Leber hereditary optic neuropathy, a type of vision loss that is passed down in families A doctor can assess your symptoms and use tests ...
bjo.bmj12d
Characterisation of thickness changes in the peripapillary retinal nerve fibre layer in patients with Leber’s hereditary optic neuropathy
Leber’s hereditary optic neuropathy (LHON) is a hereditary mitochondrial disease ... Visual acuity tests were based on the BCVA, and eye charts were standard logMAR charts (2.5 m; Star Kang Medical ...
BioSpace8d
Optic Neuropathy Market Size to Reach USD 4.6 Billion by 2035, Impelled by Advances in Personalized and Precision Medicine
Raxone (Idebenone) is a synthetic antioxidant that has shown promise in the treatment of optic neuropathy, particularly in conditions like Leber’s Hereditary Optic Neuropathy (LHON). By protecting the ...
BMJ11d
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis
Background Leber's hereditary optic neuropathy (LHON) and a multiple sclerosis (MS)-like illness appear to coexist 50 times more frequently than would be expected by chance. This association of LHON ...
pharmaphorum14d
LHON in the family: living under the spectre of an hereditary eye disease
It’s hard to imagine suddenly losing your sight in your 20s, but that’s what happened to Richard Wheeler when he developed Leber’s hereditary optic neuropathy (LHON). People with LHON ...
BMJ28d
Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases
D Valerio Carelli, Istituto di Clinica Neurologica, Universita' di Bologna, Via U.Foscolo 7, 40123 Bologna, Italycarelli{at}neuro.unibo.it The previously unrecognised association of myoclonus in two ...